Growth-hormone axis · research use only
MK-677 vs ipamorelin: oral non-peptide or injectable GHRP.
These two get compared constantly, but they aren't the same kind of molecule. MK-677 (ibutamoren) is an orally active, non-peptide ghrelin-receptor agonist with a long half-life. Ipamorelin is a small injectable peptide — a selective GHRP with a short half-life. We'll be direct: Titan does not stock MK-677. Its growth-axis offering is the CJC-1295 + Ipamorelin peptide blend, since ipamorelin is usually paired with a GHRH analog in research. Here's how the two compounds actually differ. Research use only.
MK-677: an oral non-peptide
MK-677 (ibutamoren) is not a peptide at all — it's an orally active, non-peptide ghrelin-receptor agonist. In research models it's studied for its long half-life and the convenience of oral dosing, which sets it apart from injectable secretagogues. Because it isn't a peptide, it's handled and supplied differently. Titan does not stock MK-677; its growth-axis offering is the CJC-1295 + Ipamorelin peptide blend.
What Titan stocks →Ipamorelin: a selective GHRP
Ipamorelin is a small peptide — a growth-hormone-releasing peptide (GHRP) — known in the literature for its selectivity, with relatively little effect on cortisol or prolactin compared with older GHRPs. It has a short half-life and is supplied as a lyophilized peptide for reconstitution. It's frequently studied alongside a GHRH analog such as CJC-1295, which is why the two are commonly paired.
CJC-1295 vs Ipamorelin →Why the CJC-1295 + Ipamorelin pairing
Ipamorelin (a GHRP) and CJC-1295 (a GHRH analog) act on two different pathways of the same axis, which is why research protocols often study them together as a blend rather than ipamorelin alone. MK-677 covers the ghrelin-receptor pathway by itself orally. Titan supplies the CJC-1295 + Ipamorelin blend so the peptide pairing arrives matched in one vial.
View the blend →What to verify before buying
Whether the target is an oral compound or an injectable peptide, the screen is the same: a lot-matched certificate of analysis tied to the exact vial code, an HPLC purity target, and a mass-spec identity confirmation, plus visible checkout and shipping terms. A polished product grid proves nothing on its own — the paperwork does.
How to verify a COA →Side by side
Different molecules, related axis.
Both compounds are studied on the growth-hormone axis, but they reach it differently. MK-677 is a non-peptide that activates the ghrelin receptor and stays active for a long window with oral dosing in research models. Ipamorelin is a peptide GHRP that works selectively and clears quickly, which is why it's commonly studied with a longer-acting GHRH analog like CJC-1295. The choice in a protocol comes down to molecule type, route, and duration — not a simple ranking. Titan supplies the matched CJC-1295 + Ipamorelin peptide blend and does not carry MK-677.
- MK-677 (ibutamoren)
- Non-peptide ghrelin-receptor agonist; oral; long half-life. Not stocked.
- Ipamorelin
- Selective peptide GHRP; reconstituted; short half-life.
- Common pairing
- Ipamorelin + CJC-1295 (a GHRH analog) — the blend Titan stocks.
- Format
- Lyophilized powder; reconstitute before in-vitro use.
Related reading
Keep comparing.
Sourcing a growth-axis peptide?
Open the CJC-1295 + Ipamorelin product page for pricing, vial size, and lot documentation — or read the CJC-1295 vs Ipamorelin breakdown first to confirm the pairing your protocol needs.
Compare research compounds
Other peptide comparisons researchers run before sourcing.
Each Titan comparison breaks down the structural differences, research format, and documentation a buyer should confirm — lot-matched COA, HPLC purity target, and a clear research-use boundary. Pick the pair you're evaluating.
GLP-1 / metabolic research
Growth-hormone secretagogue research
Recovery & repair research
Neuropeptide & nasal-format research